Effects of SR141716A on diazepam substitution for Δ9-tetrahydrocannabinol in rat drug discrimination

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 3, 1999, Pages 519-522

  Wiley, Jenny L ^a   Martin, Billy R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabinoid; Diazepam; GABA; SR141716A; Tetrahydrocannabinol

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; CANNABIS; DIAZEPAM; RIMONABANT; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; GABAERGIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CANNABINOIDS; DIAZEPAM; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; GABA MODULATORS; GENERALIZATION (PSYCHOLOGY); HALLUCINOGENS; MALE; PIPERIDINES; PYRAZOLES; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; TETRAHYDROCANNABINOL;

EID: 0032847529     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00130-6     Document Type: Article

References (21)

1. 9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication. Neurosci. Biobehav. Rev. 16:1992;55-62.
2. Banerjee S.P., Snyder S.H., Mechoulam R. Cannabinoids. Influence on neurotransmitter uptake in rat brain synaptosomes J. Pharmacol. Exp. Ther. 194:1975;74-81.
3. 9-tetrahydrocannabinol discrimination in rats. Psychopharmacology (Berlin). 118:1995;419-424.
4. 9-tetrahydrocannabinol. Mechanistic studies J. Clin. Pharmacol. 21:1981;227S-234S.
5. 9-tetrahydrocannabinol-induced responses and apparent agonist activity J. Pharmacol. Exp. Ther. 277:1996;586-594.
6. Compton D.R., Rice K.C., De Costa B.R., Razdan R.K., Melvin L.S., Johnson M.R., Martin B.R. Cannabinoid structure-activity relationships. Correlation of receptor binding and in vivo activities J. Pharmacol. Exp. Ther. 265:1993;218-226.
7. Hollister L.E., Gillespie H.K. The benzodiazepine receptor antagonist, flumazenil does not block clinical effects of delta-9-tetrahydrocannabinol. Life Sci. 47:1990;1655-1660.
8. 9-THC and diazepam in pigeons and gerbils. Psychopharmacology (Berlin). 94:1988;328-331.
9. Mansbach R.S., Rovetti C.C., Winston E.N., Lowe J.A. III Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats. Psychopharmacology (Berlin). 124:1996;315-322.
10. 9-tetrahydrocannabinol. Life Sci. 38:1986;1581-1589.
11. Morrison K.J., Pertwee R.G. A possible link between delta-9-tetrahydrocannabinol and GABA in mice. Br. J. Pharmacol. 86:1985;684P.
12. Pério A., Rinaldi-Carmona M., Maruani J., Barth F., Le Fur G., Soubrié P. Central mediation of the cannabinoid cue. Activity of a selective CB1 antagonist, SR 141716A Behav. Pharmacol. 7:1996;65-71.
13. Pertwee R.G., Greentree S.G. Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide. Neuropharmacology. 27:1988;485-491.
14. Pertwee R.G., Browne S.E., Ross T.M., Stretton C.D. An investigation of the involvement of GABA in certain pharmacological effects of delta-9-tetrahydrocannabinol. Pharmacol. Biochem. Behav. 40:1991;581-585.
15. Pertwee R.G., Greentree S.G., Swift P.A. Drugs which stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice. Neuropharmacology. 27:1988;1265-1270.
16. Revuelta A.V., Cheney D.L., Wood P.L., Costa E. GABAergic mediation in the inhibition of hippocampal acetylcholine turnover rate elicited by delta-9-tetrahydrocannabinol. Neuropharmacology. 18:1979;525-530.
17. Rinaldi-Carmona M., Barth F., Héaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Néliat G., Caput D., Ferrara P., Soubrié P., Brelière J.C., Le Fur G. SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240-244.
18. 9-THC in rat drug discrimination. Problems of drug dependence, 1997. Proceedings of the 59th annual scientific meeting. National Institute on Drug Abuse Research Monograph 178:1998;239 U.S. Department of Health and Human Services, Washington, DC.
19. Wiley J.L., Barrett R.L., Lowe J., Balster R.L., Martin B.R. Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology. 34:1995;669-676.
20. 9-tetrahydrocannabinol in rhesus monkeys. Drug Alcohol Depend. 40:1995;81-86.
21. 9-tetrahydrocannabinol in rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 275:1995;1-6.